Back

Tumor-induced endothelial RhoA activation mediates tumor cell transendothelial migration and metastasis

Sajib, M. S.; Zahra, F. T.; Lamprou, M.; Akwii, R. G.; Park, J. H.; Osorio, M.; Tullar, P.; Doci, C. L.; Zhang, C.; Huveneers, S.; van Buul, J. D.; Wang, M.-H.; Markiewski, M. M.; Srivastava, S. K.; Zheng, Y.; Gutkind, J. S.; Hu, J.; Bickel, U.; Maeda, D. Y.; Zebala, J. A.; Lionakis, M. S.; Trasti, S.; Mikelis, C. M.

2024-09-24 physiology
10.1101/2024.09.22.614304 bioRxiv
Show abstract

Abstract/SummaryThe endothelial barrier plays an active role in transendothelial tumor cell migration during metastasis, however, the endothelial regulatory elements of this step remain obscure. Here we show that endothelial RhoA activation is a determining factor during this process. Breast tumor cell-induced endothelial RhoA activation is the combined outcome of paracrine IL-8-dependent and cell-to-cell contact {beta}1 integrin-mediated mechanisms, with elements of this pathway correlating with clinical data. Endothelial-specific RhoA blockade or in vivo deficiency inhibited the transendothelial migration and metastatic potential of human breast tumor and three murine syngeneic tumor cell lines, similar to the pharmacological blockade of the downstream RhoA pathway. These findings highlight endothelial RhoA as a potent, universal target in the tumor microenvironment for anti-metastatic treatment of solid tumors.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.